Views: 0 Author: Site Editor Publish Time: 2026-10-06 Origin: Site
Three linked specifications define a credible serum brief: Approve the HAp material basis, delivered amount and delivery behavior together; no percentage can substitute for the other two.
Two concentration bases must be named: State both the formula-level addition basis and the dry-HAp-solids basis when the incoming material is a dispersion, paste or premix.
Four rheology behaviors matter more than one viscosity number: Review flow under application force, structure recovery, particle-settling tendency and performance in the final pack.
Three delivery elements must work as one system: The serum viscosity, applicator orifice and intended placement method need to align for the final user experience.
Four approval gates stop a headline percentage becoming an unrepeatable SKU: Confirm material/formula, dose/flow, pack/temperature and final approved sample controls before production planning.
Choose the HAp basis, delivered amount, and contact method before debating a front-label percentage. A targeted after-brushing serum needs more than an answer to “what percentage is in the tank?”
Specification layer | Question the brand must answer | What the OEM records |
|---|---|---|
Material basis | What exact HAp grade and what percentage basis is being discussed? | Supplier/item code, grade, incoming form, formula revision, calculation basis. |
Delivered dose | How much formula is expressed in one intended application? | Priming state, expression or pump method, delivered mass/volume test, target and acceptance rule. |
Contact behavior | Where is the sample placed and how should it spread? | Target surface, applicator, user step, sensory observation, residue and post-use instruction route. |
A concentration from another product or study is context, not a formula target. A published in-vitro protocol belongs to its particular material, carrier, applicator, test surface, contact setting, and pH cycle.[1] It does not establish a universal serum level, consumer direction, or finished-product claim.
A defensible percentage names what is being counted. This matters when the material arrives as powder, dispersion, premix, or a supplier compound with stated solids.
Do not approve wording such as… | Instead record… | Why it matters |
|---|---|---|
“10% HAp” | Formula addition level and whether it is calculated on supplied material or dry-HAp-solids basis. | A dispersion and a dry powder do not make the same calculation. |
“Nano HAp serum” | Exact grade, supplier/item code, and particle-information file. | “Nano” is a material description, not a purchasable finished-product specification. |
“High concentration” | The chosen level plus the delivered quantity per intended application and the defined test method. | A higher formula number can still produce inconsistent delivery or poor handling. |
The SCCS opinion assessed a specified nano-HAp material in toothpaste and mouthwash, not a generic leave-on serum, and only for defined material characteristics.[2] Do not use it to select or substantiate a serum concentration.
For identity, supplier documents, substitution control, and batch linkage, use Qiaoerna’s nHAp material-quality and batch-control guide.
Approve what leaves the applicator, not only what entered the mixing vessel. A precision tip, brush, airless pack, and pump can deliver different quantities from the same bulk formula.
Ask the OEM to write one dose-delivery method into the sample protocol:
Define the pack, nozzle/pump, prime state, and expression action.
Quantify repeated deliveries under stated conditions and retain the acceptance rule.
Recheck control after relevant storage, temperature exposure, and repeated opening/closing.
Do not release the final concentration-and-delivery specification until the chosen pack has repeatedly expressed the real formula. Use the intended formula version and documented prime state. Repeat the check if HAp level, rheology system, nozzle, closure, or pack changes.
A single cP value is insufficient because storage, dispensing, and placement impose different forces. State temperature, instrument/geometry, shear rate or stress, sample conditioning, and method; otherwise two viscosity values are not comparable.
Rheology question | What it protects | Sample evidence to request |
|---|---|---|
Does it flow under application force? | A controllable expression from the proposed applicator. | Defined extrusion/pump observation or force test under stated conditions. |
Does it recover after dispensing? | The placed serum should not immediately run away from the intended surface. | Flow/recovery observation or a relevant rheology method. |
Does it keep particles visually and physically uniform? | A supplied HAp dispersion should not create an unapproved settling or separation experience. | Appearance, settling, re-dispersion, and selected physical-stability checks. |
Does it stay consistent in the pack? | A good lab viscosity must survive its component interface and expected storage handling. | Final-pack observations with the test conditions and decision recorded. |
A 2024 in-vitro nHA/NaF/chitosan gel study measured texture, rheology, storage appearance, settling, and gel behavior under stated conditions, reporting shear-thinning and thixotropic behavior.[3] It is not a serum formula recommendation; it shows why an OEM brief needs a test protocol, not one copied number.
The applicator is part of the formula decision because it determines metering and placement. A precision tip, airless route, and brush-style head change dose, shear exposure, cleanability expectations, and sensory experience. Do not select one only because it resembles skincare.
Format route | Best decision question | What to confirm in samples |
|---|---|---|
Precision-tip tube | Can the formula be placed without over-delivery or stringing? | Tip/orifice fit, cap behavior, expression control, residue around the tip. |
Airless route | Does a metered mechanism support the planned amount and formula behavior? | Prime state, repeat delivery, return flow, pack compatibility, end-of-pack behavior. |
Brush or other placement head | Is the placement benefit worth the additional cleaning and component complexity? | Contact behavior, material compatibility, user handling, and component sourcing. |
The existing Hydroxyapatite Tooth Serum OEM brief covers broader format, hygiene, preservation, and claims questions. Use this page to decide whether formula and applicator work as one system.
A premium-looking component can still create strings, drips, settling, or excess residue. Approve it only after repeated delivery, placement, closure, and stored-sample review with the real formula.
Application method defines the rheology target. Localized placement needs a different use profile from a broader brush-on route; do not request “thick” or “lightweight” without saying what the user must do.
A usable development brief specifies:
Placement and tool: target zone plus precision tip, applicator head, brush, or another approved method.
User sequence and sensory target: routine position, residue, grit, taste release, and spread control.
Sample instruction route: record the planned placement sequence, expression action, sensory target, and observations that must be accepted in the final pack.
A laboratory exposure is not a final consumer instruction. Product-specific evidence and qualified review determine final directions.
Use sequential approvals so a promising beaker sample does not become an unverified SKU. These gates address concentration, rheology, and delivery; they record what must be rechecked when the delivery system changes.
Gate | Decision being made | Evidence to retain |
|---|---|---|
1. Material and formula basis | Is the exact HAp route and calculation basis acceptable for the intended project? | Material identity, formula version, calculation sheet, and change log. |
2. Dose and flow sample | Can the proposed formula leave the proposed applicator and be placed as intended? | Delivery protocol, observations/results, sensory feedback, exception list, approval decision. |
3. Pack and temperature sample | Does the serum remain acceptable in the representative final component system? | Component details, relevant compatibility/stability observations, stored-sample review, change control. |
4. Final approved sample | Is the formula, pack, direction route, and record set ready for the next commercial decision? | Approved formula/pack revision, dose and rheology acceptance results, application method, and outstanding delivery-system changes. |
If material grade, supplied-solids basis, dispersion approach, rheology, applicator, or use method changes, revisit the affected gate.
Before the next sample or commercial quotation, freeze the variables that determine what the final pack delivers. Record the HAp calculation basis and formula revision; intended pack, applicator, and prime state; dose-test method and acceptance rule; rheology method and test conditions; placement method; relevant pack-compatibility observations; and every change that requires re-approval.
This one-page handoff lets the brand compare samples on the same basis and tells the OEM which changes may alter delivery. For the separate leave-on format, preservation, hygiene, market and claims questions, return to the Hydroxyapatite Tooth Serum OEM brief.
No universal percentage is “right.” Confirm the exact HAp material and calculation basis, then assess delivered amount, application method, and final-pack behavior. A figure from another product, study, or material grade is not a default specification.
Not automatically. References have specific material, format, concentration, and exposure conditions. The 2025 SCCS opinion concerns defined nHAp in toothpaste and mouthwash, not an unspecified leave-on serum. Use it to set questions for material and delivery testing, not to select a serum percentage.
Set a repeatable use profile, not a standalone number: test conditions, applicator expression, placement control, structure recovery, settling behavior, and final-pack stability. It depends on the HAp material, carrier, pack, and intended placement.
Yes. Early-test a representative formula in the proposed applicator. Record prime state, delivery procedure, placed amount, residue, closure behavior, and stored-sample observations. A bulk sample cannot prove final-pack delivery.
Potentially, but each changes the delivery system. Select only after testing the actual formula for dose control, component compatibility, user handling, and the planned application method.
Request material identity and calculation basis, formula/sample revision, pack details, delivery/rheology method and results, stability or compatibility observations, change log, and the approved application method.
Repeat the affected gate when the HAp grade or calculation basis, dispersion approach, rheology system, applicator, nozzle, closure, pack architecture, or application method changes. Record the change, its expected delivery impact, and the next approval decision.
Develop a Hydroxyapatite Tooth Serum as a Controlled Delivery System. Share the HAp material route, concentration wording, application concept, applicator preference, packaging brief, and launch window. Qiaoerna can convert them into a sample and approval plan. Contact admin@qiaoerna.com.cn or use the Qiaoerna contact page.
Author: Xiaoying, Head of R&D, Qiaoerna Biotechnology Co., Ltd.
Technical Review: Qiaoerna Quality & Compliance Team — formula-basis, sample-control, delivery-system, and claims-boundary review.
Babanouri, N., Heidari, F., Hajipour, F., et al. (2025). The effect of nanohydroxyapatite serum and toothpaste on prevention of enamel demineralization around orthodontic brackets: an in vitro study. BMC Oral Health, 25, 1619. https://doi.org/10.1186/s12903-025-07014-x.
Why cited: The study uses a defined serum, applicator-based placement, and an in-vitro contact protocol. It supports specifying formula, delivery method, and test context together; it does not prescribe a commercial serum concentration or consumer directions.
Scientific Committee on Consumer Safety (SCCS). (2025). Scientific Opinion on Hydroxyapatite (nano) — Submission IV, SCCS/1677/25, adopted 26 June 2025. European Commission.
Why cited: The opinion is confined to stated material characteristics and toothpaste/mouthwash exposure conditions. It illustrates why a percentage cannot be transferred automatically to a different leave-on format.
Rafiee, A., Mozafari, N., Fekri, N., Memarpour, M., & Azadi, A. (2024). Preparation and characterization of a nanohydroxyapatite and sodium fluoride loaded chitosan-based in situ forming gel for enamel biomineralization. Heliyon, 10(2), e24217. https://doi.org/10.1016/j.heliyon.2024.e24217.
Why cited: This in-vitro gel paper measured flow/texture and physical-stability behavior under specified conditions. Its named gel is not a serum formula recommendation; it supports defining a rheology test protocol rather than relying on one viscosity number.

